Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Irinotecan, Oncology, Beijing, Internal medicine, and Cytokine-induced killer cell.
Efficacy and safety of tislelizumab plus anlotinib and irinotecan as second-line treatment for extensive-stage small cell lung cancer: a single-arm, open-label, phase II trial
Efficacy and Safety of Tislelizumab Plus Anlotinib and Irinotecan as Second-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single-Arm, Open-Label, Phase II Trial
The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer